Merck & Co of Vioxx fame is on the carpet again with their Vytorin (simvastatin or Zocor plus ezemitibe) which is suppose to give cholesterol a double whammy and may do just that but the tradeoff seems to be increased risk of prostate, gastrointestinal, and skin cancer.
So... would you rather have that dreaded 'high cholesterol' or try your luck with cancer?
See this link to a Reuters article and also read this article in Natural News where they state that Merck's belatedly released data "... reveals a whopping 50% increase in cancer risk compared to patients taking a placebo! Hilariously, Merck says the difference is due to "chance." Isn't it funny how all the results they WANT to see in clinical trials are due to their drugs, but all the results they DON'T want to see are due to "chance?"
Also pay attention to Natural News list of related articles.
No comments:
Post a Comment
I appreciate appropriate comments but reserve the right to publish those with credible, verifiable, significant information to contribute to the topic at hand. I will not post comments with commercial content nor those containing personal attacks. Thank You.